Novartis AG vs Reddit Inc — how do they compare? Novartis AG trades at $143.71 (market cap $268.57B), while Reddit Inc trades at $161.37 (market cap $30.10B). The key difference: Novartis AG is far larger — about 8.9× Reddit Inc's market cap, and Novartis AG pays a 3.31% dividend while Reddit Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novartis AG for 82 Days and Reddit Inc for 26 Days on average.
| NVS | RDDT | |
|---|---|---|
Market Cap | $268.57B | $30.10B |
Volume | 1,532,573 | 4,560,440 |
Sector | Health | Media |
52-Week High | $168.62 | $258.93 |
52-Week Low | $121.80 | $121.84 |
Typical Hold Time | 82 Days | 26 Days |
Enterprise Value | $309.89B | $27.34B |
Dividend Yield | 3.31% | — |
Signals from Pluang's Aura AI — not financial advice
Novartis (NVS) trades at $143.22, down 0.04% on the day, near the analyst consensus price target of $146. The stock shows mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company reported strong 2025 revenue of $56.67B and net income of $13.98B, with a robust net margin of 24.67%. Recent developments include a significant $7.8B licensing deal with China's Abogen for mRNA therapy, though this follows clinical setbacks in other drug programs.
The outlook is cautiously optimistic. The Abogen deal expands the pipeline in autoimmune diseases, a growth area, and analyst consensus leans Hold with a slight upside to the price target. Key risks include integration challenges from recent acquisitions, pipeline volatility after trial failures, and investor scrutiny over M&A strategy. Earnings momentum is mixed, with a recent beat in Q2 but a miss in Q1, requiring consistent execution to justify current valuations.
Reddit (RDDT) trades at $161.53, up 5.73% with strong earnings momentum after beating Q2 2026 EPS estimates. The stock shows bullish technical signals with support at $154 and resistance at $163. Fundamentally, the company maintains exceptional 91.44% gross margins and 31.35% net income margin, with revenue projected to grow from $2.2B to $2.8B in 2026. Recent news highlights international expansion and AI partnerships while facing competitive pressures.
Outlook remains positive with 65.52% analyst buy ratings and $202.52 consensus target, though risks include CEO stock sales and competitive threats. The valuation appears elevated at 36.39 P/E, but strong profitability and growth trajectory support the bullish case for investors seeking social media exposure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →